Form 4: VolitionRX Director Ethel Rubin Acquires 15,000 Restricted Stock Units

Director Ethel Rubin acquired 15,000 restricted stock units in VolitionRX Ltd under the company's 2015 Stock Incentive Plan.

Summary

• On September 30, 2024, Ethel Rubin, a director of VolitionRX Ltd, acquired 15,000 restricted stock units (RSUs).
• The RSUs were granted under the Issuer's 2015 Stock Incentive Plan.
• The RSUs vest in three equal installments of 5,000 units each on September 30, 2025, September 30, 2026, and September 30, 2027.
• Upon vesting and settlement, Rubin will receive common stock shares equal to the number of vested RSUs.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as it reflects insider confidence through equity ownership, but it's a routine transaction.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.

Future Outlook

The vesting schedule of the RSUs indicates a long-term commitment by the director to the company's success.

Industry Context

Stock grants to directors are a common practice to align their interests with those of shareholders and incentivize long-term value creation.

Stakeholder Impact

• The RSU grant aligns the director's interests with those of the shareholders, potentially leading to decisions that benefit the company's long-term value.

Key Dates